Related Experiment Video
Updated: Jan 23, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
Liam J O'Brien1, Camille Guillerey2, Kristen J Radford3
1Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia. liam.obrien@mater.uq.edu.au.
Dendritic cell (DC) vaccination shows promise for leukemia treatment, overcoming immunosuppression and improving survival in Acute Myeloid Leukemia (AML). Further strategies aim to enhance DC function for better outcomes in leukemia patients.
Area of Science:
- * Immunology
- * Hematology
- * Oncology
Background:
- * Leukemias are clonal disorders of immature leukocytes, often relapsing despite targeted therapies.
- * Dendritic cell (DC) vaccination offers potential for long-lasting anti-tumor immunity but faces barriers like immunosuppression and disrupted hematopoiesis in leukemias.
- * Cancer cells produce immunosuppressive factors hindering DC and T cell function, while leukemia disrupts the bone marrow microenvironment.
Purpose of the Study:
- * To review the phenotype and function of DCs in leukemia.
- * To explore strategies for harnessing DCs in leukemia patients.
- * To discuss recent clinical successes and future directions for DC vaccination in AML and other leukemias.
Main Methods:
- * Review of existing literature on DC biology in leukemia.
- * Analysis of clinical trial data for DC vaccination in leukemia.
- * Discussion of novel strategies to enhance DC function and anti-leukemia immunity.
Main Results:
- * Recent clinical trials demonstrate extended survival for Acute Myeloid Leukemia (AML) patients using DC vaccination.
- * Despite challenges, DC vaccination has shown safety and emerging efficacy in certain leukemia subtypes.
- * Understanding DC function and the leukemia microenvironment is key to improving vaccine efficacy.
Conclusions:
- * Dendritic cell vaccination is a promising immunotherapy for leukemia, particularly AML.
- * Overcoming immunosuppression and enhancing DC function are critical for successful leukemia treatment.
- * New strategies hold potential to improve prognosis for AML and other leukemias through enhanced DC-based immunotherapy.
Related Concept Videos
Vaccinations
Neurons: The Cell Body and the Dendrites
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Prevention of Further Absorption of Poison
Preventive Healthcare Services

